Literature DB >> 22024615

Development and cross-validation of the UPSA short form for the performance-based functional assessment of patients with mild cognitive impairment and Alzheimer disease.

Jesus J Gomar1, Philip D Harvey, Maria T Bobes-Bascaran, Peter Davies, Terry E Goldberg.   

Abstract

BACKGROUND: Functional capacity includes basic and complex behaviors necessary to independently live in the community. It has been found that patients with cognitive impairment have daily living functional skills altered at very early stages of illness.
OBJECTIVES: 1) To develop and validate a brief scale derived from the University of California, San Diego, performance-based skills assessment (UPSA); 2) to cross-validate this new UPSA short form with an independent healthy elderly sample.
METHOD: Fifty-one healthy elderly subjects, 26 mild cognitive impairment (MCI) subjects defined per Petersen's criteria, and 22 probable Alzheimer Disease (AD) subjects according to National Institute of Neurological and Communicative Disorders and Stroke-AD and Related Disorders Association criteria were included. For cross-validation purpose, a comparison group of 108 older healthy subjects with Mini-Mental scores of 25 or greater was also recruited. A modified four-functional domain version of the UPSA was administered.
RESULTS: Communication and comprehension/planning domains accounted for almost 90% of the variance (R = 0.89) and in all models entered first and second, respectively. An UPSA short form using these two domains was significantly correlated with the full UPSA scale in all the groups examined: 0.86 for healthy controls; 0.87 for MCI; and 0.88 for AD. Acceptable sensitivity and specificity values for the UPSA short form were found in receiver operating characteristic (ROC) analysis. A correlation of 0.80 was found between the short and the full UPSA scales in the cross-validation sample.
CONCLUSIONS: The UPSA short form is a rapid, reliable, and efficient measure of functional capacity that is able to detect performance impairment in an ecologically valid setting in much less time compared with the extended form of the scale. Furthermore, it demonstrated adequate discriminative properties among healthy subjects, MCI patients, and AD patients.

Entities:  

Mesh:

Year:  2011        PMID: 22024615     DOI: 10.1097/JGP.0b013e3182011846

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  18 in total

1.  Depressive symptoms and gait dysfunction in the elderly.

Authors:  Tamar C Brandler; Cuiling Wang; Mooyeon Oh-Park; Roee Holtzer; Joe Verghese
Journal:  Am J Geriatr Psychiatry       Date:  2012-05       Impact factor: 4.105

2.  Memory improvement in African Americans with amnestic mild cognitive impairment.

Authors:  Barry W Rovner; Robin J Casten; Benjamin Leiby
Journal:  Int J Geriatr Psychiatry       Date:  2019-06-18       Impact factor: 3.485

Review 3.  Performance-based and Observational Assessments in Clinical Trials Across the Alzheimer's Disease Spectrum.

Authors:  Philip D Harvey; Stephanie Cosentino; Rosie Curiel; Terry E Goldberg; Jeffrey Kaye; David Loewenstein; Daniel Marson; David Salmon; Keith Wesnes; Holly Posner
Journal:  Innov Clin Neurosci       Date:  2017-02-01

4.  Activities of daily living: where do they fit in the diagnosis of Alzheimer's disease?

Authors:  Gad A Marshall; Rebecca E Amariglio; Reisa A Sperling; Dorene M Rentz
Journal:  Neurodegener Dis Manag       Date:  2012-10-01

5.  Assessment of Age-Related Differences in Functional Capacity Using the Virtual Reality Functional Capacity Assessment Tool (VRFCAT).

Authors:  A S Atkins; I Stroescu; N B Spagnola; V G Davis; T D Patterson; M Narasimhan; P D Harvey; R S E Keefe
Journal:  J Prev Alzheimers Dis       Date:  2015-06

Review 6.  Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia.

Authors:  Philip D Harvey; David A Loewenstein; Sara J Czaja
Journal:  Neurobiol Dis       Date:  2012-10-31       Impact factor: 5.996

7.  Preventing Cognitive Decline in Black Individuals With Mild Cognitive Impairment: A Randomized Clinical Trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin Leiby
Journal:  JAMA Neurol       Date:  2018-12-01       Impact factor: 18.302

8.  Rates of Cognitive and Functional Impairments in Older Adults Residing in a Continuing Care Senior Housing Community.

Authors:  Ryan Van Patten; Zanjbeel Mahmood; Tanya T Nguyen; Jacqueline E Maye; Ho-Cheol Kim; Dilip V Jeste; Elizabeth W Twamley
Journal:  J Int Neuropsychol Soc       Date:  2021-03-22       Impact factor: 2.892

9.  Examination of Variables That May Affect the Relationship Between Cognition and Functional Status in Individuals with Mild Cognitive Impairment: A Meta-Analysis.

Authors:  Courtney Mcalister; Maureen Schmitter-Edgecombe; Richard Lamb
Journal:  Arch Clin Neuropsychol       Date:  2016-01-06       Impact factor: 2.813

10.  The Computerized Functional Skills Assessment and Training Program: Sensitivity to Global Cognitive Impairment, Correlations With Cognitive Abilities, and Factor Structure.

Authors:  Philip D Harvey; Daniela Bolivar Forero; Lauren B Ahern; Lize Tibiriçá; Peter Kallestrup; Sara J Czaja
Journal:  Am J Geriatr Psychiatry       Date:  2020-09-07       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.